Page last updated: 2024-09-04

1-methyl-4-phenyl-2,3-dihydropyridinium and salicylic acid

1-methyl-4-phenyl-2,3-dihydropyridinium has been researched along with salicylic acid in 1 studies

*Salicylic Acid: A compound obtained from the bark of the white willow and wintergreen leaves. It has bacteriostatic, fungicidal, and keratolytic actions. [MeSH]

*Salicylic Acid: A compound obtained from the bark of the white willow and wintergreen leaves. It has bacteriostatic, fungicidal, and keratolytic actions. [MeSH]

Compound Research Comparison

Studies
(1-methyl-4-phenyl-2,3-dihydropyridinium)
Trials
(1-methyl-4-phenyl-2,3-dihydropyridinium)
Recent Studies (post-2010)
(1-methyl-4-phenyl-2,3-dihydropyridinium)
Studies
(salicylic acid)
Trials
(salicylic acid)
Recent Studies (post-2010) (salicylic acid)
460322,8647718,704

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiueh, CC; Obata, T1

Other Studies

1 other study(ies) available for 1-methyl-4-phenyl-2,3-dihydropyridinium and salicylic acid

ArticleYear
In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP+.
    Journal of neural transmission. General section, 1992, Volume: 89, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dialysis; Dopamine; Free Radicals; Hydroxides; Hydroxyl Radical; Male; Nerve Endings; Perfusion; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Salicylates; Salicylic Acid; Substantia Nigra

1992